Nifty
:
24426.85
Sensex
:
79809.65
-74.05 (-0.30%)
-270.92 (-0.34%)
Nifty
Sensex
:
:
24426.85
79809.65
-74.05 (-0.30%)
-270.92 (-0.34%)

Apollo Hospitals Enterprise Ltd.

Hospital & Healthcare Services

Rating :
64/99

BSE: 508869 | NSE: APOLLOHOSP

NSE BSE
7610.00
29-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  7670
  •  7744
  •  7586
  •  7728.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  481590
  •  3677150571.5
  •  7980
  •  6001

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,09,373.39
  • 69.51
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,13,288.39
  • 0.25%
  • 13.10

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 29.34%
  • 0.34%
  • 3.99%
  • FII
  • DII
  • Others
  • 43.49%
  • 20.53%
  • 2.31%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.37
  • 15.59
  • 9.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.08
  • 21.67
  • 8.07

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.33
  • 57.41
  • 18.80

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 85.65
  • 88.23
  • 87.46

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.49
  • 11.92
  • 12.24

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.06
  • 35.16
  • 34.46

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
62.5
99.62
132.6
168.74
P/E Ratio
121.76
76.39
57.39
45.10
Revenue
19059
21889
25997
30303
EBITDA
2391
3040
3739
4498
Net Income
899
1443
1923
2432
ROA
5.8
8.9
10.3
11.8
P/B Ratio
14.19
13.55
11.20
9.21
ROE
13.68
18.82
20.78
21.54
FCFF
520
864
1388
1998
FCFF Yield
Net Debt
3715
1306
487
-780
BVPS
536.28
561.48
679.72
826.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
5,842.10
5,085.60
14.88%
5,592.20
4,943.90
13.11%
5,526.90
4,850.60
13.94%
5,589.30
4,846.90
15.32%
Expenses
4,990.20
4,410.50
13.14%
4,822.50
4,303.40
12.06%
4,765.40
4,236.90
12.47%
4,773.80
4,219.40
13.14%
EBITDA
851.90
675.10
26.19%
769.70
640.50
20.17%
761.50
613.70
24.08%
815.50
627.50
29.96%
EBIDTM
14.58%
13.27%
13.76%
12.96%
13.78%
12.65%
14.59%
12.95%
Other Income
40.20
37.20
8.06%
61.10
28.10
117.44%
63.80
27.80
129.50%
38.20
22.20
72.07%
Interest
108.30
116.40
-6.96%
114.80
119.30
-3.77%
109.80
112.60
-2.49%
117.50
111.30
5.57%
Depreciation
214.70
177.40
21.03%
211.00
189.70
11.23%
184.60
167.00
10.54%
184.50
163.40
12.91%
PBT
569.10
418.50
35.99%
505.00
359.60
40.43%
530.90
361.90
46.70%
551.70
376.90
46.38%
Tax
141.70
114.50
23.76%
101.00
109.80
-8.01%
156.80
108.90
43.99%
161.70
130.20
24.19%
PAT
427.40
304.00
40.59%
404.00
249.80
61.73%
374.10
253.00
47.87%
390.00
246.70
58.09%
PATM
7.32%
5.98%
7.22%
5.05%
6.77%
5.22%
6.98%
5.09%
EPS
30.10
21.23
41.78%
27.09
17.65
53.48%
25.89
17.06
51.76%
26.34
16.20
62.59%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
22,550.50
21,794.00
19,059.20
16,612.50
14,662.60
10,560.00
11,246.80
9,617.40
8,243.47
7,255.70
6,214.65
Net Sales Growth
14.31%
14.35%
14.73%
13.30%
38.85%
-6.11%
16.94%
16.67%
13.61%
16.75%
 
Cost Of Goods Sold
11,734.60
11,310.00
9,805.50
8,574.30
7,573.50
5,684.20
5,498.90
4,660.90
4,032.66
3,598.88
3,054.74
Gross Profit
10,815.90
10,484.00
9,253.70
8,038.20
7,089.10
4,875.80
5,747.90
4,956.50
4,210.81
3,656.83
3,159.91
GP Margin
47.96%
48.10%
48.55%
48.39%
48.35%
46.17%
51.11%
51.54%
51.08%
50.40%
50.85%
Total Expenditure
19,351.90
18,772.20
16,668.50
14,562.90
12,477.50
9,426.90
9,665.80
8,554.70
7,452.09
6,548.95
5,534.38
Power & Fuel Cost
-
266.20
247.20
217.50
193.70
169.70
213.00
183.80
166.68
127.89
122.80
% Of Sales
-
1.22%
1.30%
1.31%
1.32%
1.61%
1.89%
1.91%
2.02%
1.76%
1.98%
Employee Cost
-
2,769.20
2,493.70
2,176.70
1,786.50
1,601.00
1,852.90
1,598.20
1,404.39
1,196.50
1,023.55
% Of Sales
-
12.71%
13.08%
13.10%
12.18%
15.16%
16.47%
16.62%
17.04%
16.49%
16.47%
Manufacturing Exp.
-
2,612.00
2,290.90
1,981.00
1,800.80
492.60
504.30
419.80
433.58
414.16
387.28
% Of Sales
-
11.98%
12.02%
11.92%
12.28%
4.66%
4.48%
4.37%
5.26%
5.71%
6.23%
General & Admin Exp.
-
1,634.50
1,707.10
1,494.40
1,009.10
1,253.80
1,366.30
1,551.20
1,291.65
1,116.65
868.33
% Of Sales
-
7.50%
8.96%
9.00%
6.88%
11.87%
12.15%
16.13%
15.67%
15.39%
13.97%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
180.30
124.10
119.00
113.90
225.60
230.40
140.80
123.13
94.88
0.00
% Of Sales
-
0.83%
0.65%
0.72%
0.78%
2.14%
2.05%
1.46%
1.49%
1.31%
1.25%
EBITDA
3,198.60
3,021.80
2,390.70
2,049.60
2,185.10
1,133.10
1,581.00
1,062.70
791.38
706.75
680.27
EBITDA Margin
14.18%
13.87%
12.54%
12.34%
14.90%
10.73%
14.06%
11.05%
9.60%
9.74%
10.95%
Other Income
203.30
200.30
106.30
90.30
78.20
49.10
33.20
32.40
33.95
44.33
52.54
Interest
450.40
458.50
449.40
380.80
378.60
449.20
532.80
327.00
295.07
257.35
180.02
Depreciation
794.80
757.50
687.00
615.40
600.70
573.10
619.70
395.50
359.03
314.04
263.83
PBT
2,156.70
2,006.10
1,360.60
1,143.70
1,284.00
159.90
461.70
372.60
171.24
179.69
288.95
Tax
561.20
534.00
445.50
256.20
477.00
84.70
225.10
173.40
111.91
90.96
96.90
Tax Rate
26.02%
26.62%
32.70%
22.40%
30.23%
38.38%
34.11%
46.54%
65.35%
50.62%
31.78%
PAT
1,595.50
1,445.90
898.60
862.30
1,048.30
149.60
458.00
235.00
117.19
178.60
209.14
PAT before Minority Interest
1,538.40
1,505.10
935.00
887.50
1,101.10
136.00
434.90
199.20
59.33
88.73
207.99
Minority Interest
-57.10
-59.20
-36.40
-25.20
-52.80
13.60
23.10
35.80
57.86
89.87
1.15
PAT Margin
7.08%
6.63%
4.71%
5.19%
7.15%
1.42%
4.07%
2.44%
1.42%
2.46%
3.37%
PAT Growth
51.45%
60.91%
4.21%
-17.74%
600.74%
-67.34%
94.89%
100.53%
-34.38%
-14.60%
 
EPS
110.95
100.55
62.49
59.97
72.90
10.40
31.85
16.34
8.15
12.42
14.54

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
8,212.30
6,935.40
6,197.40
5,623.30
4,602.50
3,339.10
3,333.50
3,251.51
3,313.20
3,331.13
Share Capital
71.90
71.90
71.90
71.90
71.90
69.60
69.60
69.56
73.01
69.56
Total Reserves
7,855.30
6,691.10
6,040.60
5,542.50
4,524.30
3,266.50
3,261.10
3,180.05
3,238.91
3,260.64
Non-Current Liabilities
7,778.30
5,033.90
6,225.50
6,242.00
5,590.10
6,482.70
4,613.00
4,423.17
4,398.65
2,700.91
Secured Loans
1,967.30
2,231.40
1,923.70
2,408.20
2,466.00
2,852.00
2,868.70
2,728.43
2,477.64
2,303.08
Unsecured Loans
2,449.70
4.20
13.90
19.00
7.40
0.00
83.40
195.37
475.74
146.70
Long Term Provisions
454.40
349.90
1,723.40
1,341.60
1,061.00
1,011.20
883.00
784.96
701.39
3.27
Current Liabilities
4,579.40
4,664.50
3,324.90
2,434.30
2,038.00
2,337.30
1,955.40
1,567.23
963.36
1,249.83
Trade Payables
2,240.50
2,368.60
1,915.60
1,631.80
1,160.00
908.80
713.10
606.02
501.19
550.19
Other Current Liabilities
1,567.30
1,425.90
684.80
472.10
382.40
807.80
640.80
501.70
295.59
446.16
Short Term Borrowings
590.20
725.30
609.10
208.50
385.90
497.50
498.20
379.17
70.69
182.93
Short Term Provisions
181.40
144.70
115.40
121.90
109.70
123.20
103.30
80.33
95.89
70.55
Total Liabilities
21,010.60
17,018.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
7,359.80
Net Block
10,985.40
9,660.50
8,515.70
8,290.90
6,773.00
7,426.20
4,975.10
4,765.71
4,583.29
3,997.42
Gross Block
16,180.60
14,193.30
12,473.20
11,717.50
9,612.40
10,222.00
6,599.50
6,023.63
5,499.02
4,609.14
Accumulated Depreciation
5,195.20
4,532.80
3,957.50
3,426.60
2,839.40
2,795.80
1,624.40
1,257.92
915.73
611.73
Non Current Assets
13,981.20
11,739.20
11,744.70
10,518.70
8,789.00
9,643.00
7,755.60
7,154.22
6,670.57
5,385.23
Capital Work in Progress
921.00
872.80
609.90
45.50
233.90
235.60
821.80
712.20
346.86
561.56
Non Current Investment
1,054.50
302.10
281.40
314.80
350.20
365.10
399.30
301.26
307.96
270.65
Long Term Loans & Adv.
944.20
833.90
2,178.80
1,769.30
1,421.30
1,598.40
1,431.60
1,254.62
1,325.53
498.28
Other Non Current Assets
73.30
66.50
154.80
93.50
10.60
17.70
127.80
120.43
106.93
57.33
Current Assets
7,029.40
5,279.70
4,337.00
4,060.60
3,641.50
2,646.80
2,281.80
2,220.13
2,129.22
1,974.57
Current Investments
1,432.30
684.00
292.20
501.30
997.80
74.90
68.80
57.87
105.84
81.73
Inventories
480.80
459.80
390.10
431.90
249.50
737.80
584.70
565.84
466.87
406.13
Sundry Debtors
3,016.10
2,514.90
2,234.20
1,764.70
1,331.10
1,027.20
1,023.20
825.19
750.53
609.37
Cash & Bank
1,360.20
933.80
775.80
924.00
724.40
466.80
346.90
417.25
524.50
378.79
Other Current Assets
740.00
258.20
226.40
141.00
338.70
340.10
258.20
353.97
281.47
498.55
Short Term Loans & Adv.
452.60
429.00
418.30
297.70
193.90
96.70
79.40
112.29
223.03
437.25
Net Current Assets
2,450.00
615.20
1,012.10
1,626.30
1,603.50
309.50
326.40
652.90
1,165.86
724.74
Total Assets
21,010.60
17,018.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
7,359.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
2,136.40
1,920.20
1,376.90
1,696.00
1,264.50
1,292.90
905.20
536.96
622.55
597.17
PBT
2,031.40
1,380.50
1,100.50
1,578.10
221.50
656.90
373.60
59.56
131.12
305.25
Adjustment
1,194.90
1,199.20
1,108.40
681.40
1,079.80
1,012.50
770.10
807.85
703.53
425.00
Changes in Working Capital
-603.90
-192.80
-450.00
-359.20
-72.10
-70.40
-46.00
-205.35
-78.48
10.82
Cash after chg. in Working capital
2,622.40
2,386.90
1,758.90
1,900.30
1,229.20
1,599.00
1,097.70
662.06
756.17
741.07
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-486.00
-466.70
-382.00
-204.30
35.30
-306.10
-192.50
-125.10
-133.62
-141.19
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.71
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-3,380.60
-1,537.20
-870.60
-847.20
-863.40
-288.80
-710.60
-404.91
-1,151.88
-888.21
Net Fixed Assets
-830.60
-1,399.90
-324.10
-166.80
1,127.70
-2,378.60
-622.09
-796.57
-582.72
-278.38
Net Investments
-1,289.50
-404.00
-158.10
31.60
-1,014.40
9.00
-185.02
163.48
-186.58
-164.16
Others
-1,260.50
266.70
-388.40
-712.00
-976.70
2,080.80
96.51
228.18
-382.58
-445.67
Cash from Financing Activity
1,316.80
-311.10
-633.00
-791.60
-340.10
-909.60
-214.70
-108.50
476.95
329.93
Net Cash Inflow / Outflow
72.60
71.90
-126.70
57.20
61.00
94.50
-20.10
23.55
-52.37
38.89
Opening Cash & Equivalents
505.50
433.50
546.30
388.70
380.70
286.20
306.30
282.78
335.15
339.90
Closing Cash & Equivalent
578.10
505.50
433.40
546.50
425.20
380.70
286.20
306.33
282.78
378.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
550.72
469.76
424.53
389.89
319.08
239.10
238.71
233.02
237.25
238.81
ROA
7.92%
5.65%
5.79%
8.15%
1.10%
3.90%
2.05%
0.65%
1.10%
3.01%
ROE
20.51%
14.54%
15.16%
21.60%
3.44%
13.08%
6.07%
1.81%
2.68%
6.41%
ROCE
21.19%
19.27%
17.78%
24.92%
9.32%
17.13%
10.24%
7.12%
6.94%
8.57%
Fixed Asset Turnover
1.44
1.43
1.37
1.37
1.06
1.34
1.52
1.43
1.44
1.40
Receivable days
46.32
45.47
43.93
38.53
40.76
33.27
35.08
34.88
34.21
35.79
Inventory Days
7.88
8.14
9.03
8.48
17.06
21.46
21.83
22.86
21.96
22.21
Payable days
74.37
79.74
75.50
67.27
66.42
34.00
33.10
31.52
33.88
36.38
Cash Conversion Cycle
-20.18
-26.12
-22.54
-20.26
-8.60
20.73
23.81
26.22
22.28
21.62
Total Debt/Equity
0.67
0.47
0.44
0.47
0.62
1.08
1.10
1.06
0.95
0.85
Interest Cover
5.45
4.07
4.00
5.17
1.49
2.24
2.14
1.58
1.70
2.69

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Apollo Hospitals Enterprise gets nod to acquire 50% stake of Apollo Gleneagles PET-CT
    13th Aug 2025, 15:41 PM

    The Board of Directors of the company in its meeting held on August 12, 2025, has approved the same

    Read More
  • Apollo Hospitals Enterprise reports 42% jump in Q1 consolidated net profit
    13th Aug 2025, 15:28 PM

    The total consolidated income of the company increased by 14.83% at Rs 5882.30 crore for Q1FY26

    Read More
  • Apollo Hospital Ent. - Quarterly Results
    12th Aug 2025, 19:15 PM

    Read More
  • Apollo Hospitals Enterprise joins hands with Siemens Healthineers
    24th Jul 2025, 14:38 PM

    AI-driven disease progression models shall play a pivotal role in early detection of fibrosis, allowing timely interventions, cost-effective screening, and improved patient outcomes

    Read More
  • Apollo Hospitals Enterprise reports 60% jump in Q4 consolidated net profit
    2nd Jun 2025, 11:48 AM

    The total consolidated income of the company increased by 13.70% at Rs 5653.30 crore for Q4FY25

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.